McIntosh is an experienced R&D and product development leader with a background in the pharmaceutical and biotech industries, most recently as Vice President, Translational Research, at Caprion Biosciences Inc. in Montreal. She previously held senior management and product development positions at Osprey Pharmaceuticals Ltd., Advanced Research Technologies Inc. and Argose Inc.
“Laura has a broad range of scientific and product development credentials,” said Inocucor President and CEO Donald R. Marvin. “Her team will play a critical role in developing our next-generation biological products for growers and greenhouse operators.”
McIntosh will manage Product R&D activities at Inocucor’s 20,000-square-foot Technical Center of Excellence in Montreal. Her 20-person team will focus on developing new products and formulations, including innovative biocontrol products that combat economically devastating diseases in crops such as strawberries, tomatoes and potatoes.
Inocucor uses a patented fermentation process to combine multi-strains of bacteria and yeasts into powerful soil and plant optimizers that are safe for people and the environment. Growers in Canada and the U.S. are using Inocucor’s first two biostimulatory products to naturally improve crop yields, shorten growing periods and produce healthier, more resilient soils.
McIntosh will interface with production scientists at Inocucor’s 30,000-square-foot U.S. headquarters and commercialization facility currently under construction in Centennial, Colo.
After completing her Ph.D. in Human Anatomy and Cell Biology at the University of Manitoba, she held an NSERC post-doctoral fellowship at the National Research Council of Canada. She holds an M.S. degree in Human Anatomy and Cell Science from the University of Manitoba, and a B.Sc. in Zoology from Brandon University in Brandon, Manitoba.
For more information
Inocucor